LIZHUANG LIU received the Ph.D. degree in biomedical engineering fromXi’an Jiaotong University, Xi’an, China, in 2003. He has been a senior engineer and principal investigator with the Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, China, where he is currently the leader of the Industrial Artificial Intelligence Team and the director of the Joint Laboratory for Image and Video Processing. He has led multiple national-level research projects funded by the Ministry of Science and Technology, the Ministry of Industry and Information Technology, and the Chinese Academy of Sciences. His research interests include artificial intelligence and deep learning model design, image and video processing algorithm optimization, lightweight network implementation, and their applications in healthcare, intelligent security, and 3D digital twins. His team recently achieved a breakthrough in AI-driven prediction models for lipid nanoparticles in mRNA drug delivery systems, proposing a multimodal interpretable model (TransMA) based on Transformer and Mamba architectures, with results published in Briefings in Bioinformatics.
LIZHUANG LIU received the Ph.D. degree in biomedical engineering fromXi’an Jiaotong University, Xi’an, China, in 2003. He has been a senior engineer and principal investigator with the Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, China, where he is currently the leader of the Industrial Artificial Intelligence Team and the director of the Joint Laboratory for Image and Video Processing. He has led multiple national-level research projects funded by the Ministry of Science and Technology, the Ministry of Industry and Information Technology, and the Chinese Academy of Sciences. His research interests include artificial intelligence and deep learning model design, image and video processing algorithm optimization, lightweight network implementation, and their applications in healthcare, intelligent security, and 3D digital twins. His team recently achieved a breakthrough in AI-driven prediction models for lipid nanoparticles in mRNA drug delivery systems, proposing a multimodal interpretable model (TransMA) based on Transformer and Mamba architectures, with results published in Briefings in Bioinformatics.